Boston, MA -- (SBWIRE) -- 02/15/2013 -- Eqalix, Inc. (Eqalix) is a medicine development company. It provides novel nano-materials for the repair and regeneration of diseased, traumatized, and aging tissues. The company has commercial licensing for technologies to be developed in the fields of aesthetic dermatology, wound treatments, vascular replacements, and traumatic damage to peripheral nerves. Its pipeline products include plant-protein based nano-fiber scaffolds; and small-diameter hybrid vessels. The company's brands include RegeNerve, CardioVessel, MaxiCell3D, RenalEase, BioSquareEQ and OmegaSkin. Eqalix is headquartered in Reston, Virginia, the US.

View Full Report Details and Table of Contents

It aims to develop technologies in a staged approach and generate revenue from the consumer market to further commercialization on these technologies. It intends to work closely with co-development partners, and seek government grants and sponsorships.

This report is a source for data, analysis and actionable intelligence on the Eqalix, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market
- Qiagen N.V. (QIA) - Product Pipeline Analysis
- Cepheid (CPHD) - Product Pipeline Analysis
- Siemens Healthcare - Product Pipeline Analysis
- bioMerieux S.A. (BIM) - Product Pipeline Analysis
- Philips Healthcare - Product Pipeline Analysis
- Quidel Corporation (QDEL) - Product Pipeline Analysis
- Siemens Healthcare Diagnostics, Inc. - Product Pipeline Analysis
- MicroPort Scientific Corporation (853) - Product Pipeline Analysis
- Alere Inc. (ALR) - Product Pipeline Analysis